StockGlow

Theralase Technologies Inc. (TTX.F)

Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of energy activated small molecules and associated drug formulations in Canada, the United States, and internationally.

0.17+0.03%Healthcare
Compare TTX.F with
StockGlow Score
79
Leaning Bullish
BearishBullish
1 year ago+37.5%

The outlook

Theralase Technologies Inc. currently reads as leaning bullish based on above its 50- & 200-day averages, 56% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range56% of the way from its 52-week low to high
Market cap
$48.8M
52-wk high
0.23
52-wk low
0.08
50-day avg
0.14
200-day avg
0.14
Trailing P/E
—

Similar stocks

JNX0.FTherma Bright Inc.$0.02+0.00%TLTFFTheralase Technologies Inc.$0.20+5.26%VPTDFVentripoint Diagnostics Ltd.$0.08+5.92%TBRIFTherma Bright Inc.$0.04+0.00%TTX.SGTheralase Technologies Inc$0.17+1.23%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy